Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell lines

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 2, 2011, Pages 321-330

  Kalalinia, Fatemeh ^a   Elahian, Fatemeh ^a   Behravan, Javad ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ABCG2; Celecoxib; Cyclooxygenase 2; Multidrug resistance

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CELECOXIB; CYCLOOXYGENASE 2; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG TRANSPORT; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 85028113282     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0893-9     Document Type: Article

References (32)

1. R Allikmets LM Schriml A Hutchinson V Romano-Spica M Dean 1998 A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance Cancer Res 58 5337 5339 1:CAS:528: DyaK1cXotVSkt7Y%3D 9850061
2. Y Cao SM Prescott 2002 Many actions of cyclooxygenase-2 in cellular dynamics and in cancer J Cell Physiol 190 279 286 1:CAS:528:DC%2BD38XhtV2hu7g%3D 10.1002/jcp.10068 11857443 (Pubitemid 34111968)
3. CH Choi 2005 ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal Cancer Cell Int 5 30 10.1186/1475-2867-5-30 16202168 (Pubitemid 41554983)
4. JE Diestra GL Scheffer I Catala M Maliepaard JH Schellens RJ Scheper JR Germa-Lluch MA Izquierdo 2002 Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material J Pathol 198 213 219 1:CAS:528:DC%2BD3sXivV2jsrY%3D 10.1002/path.1203 12237881 (Pubitemid 35243879)
5. LA Doyle DD Ross 2003 Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) Oncogene 22 7340 7358 10.1038/sj.onc.1206938 14576842 (Pubitemid 37487163)
6. LA Doyle W Yang LV Abruzzo T Krogmann Y Gao AK Rishi DD Ross 1998 A multidrug resistance transporter from human MCF-7 breast cancer cells Proc Natl Acad Sci U S A 95 15665 15670 1:CAS:528:DyaK1MXhvFeitQ%3D%3D 10.1073/pnas.95.26.15665 9861027 (Pubitemid 29018757)
7. RS Fife B Stott RE Carr 2004 Effects of a selective cyclooxygenase-2 inhibitor on cancer cells in vitro Cancer Biol Ther 3 228 232 1:CAS:528:DC%2BD2cXkvF2hs7s%3D 14726667
8. RL Fine J Patel BA Chabner 1988 Phorbol esters induce multidrug resistance in human breast cancer cells Proc Natl Acad Sci U S A 85 582 586 1:CAS:528:DyaL1cXhtVKjtLc%3D 10.1073/pnas.85.2.582 3422442
9. G Gasparini R Longo R Sarmiento A Morabito 2003 Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncol 4 605 615 1:CAS:528:DC%2BD3sXnvVKksbo%3D 10.1016/S1470-2045(03)01220-8 14554238 (Pubitemid 37258402)
10. EM Gilhooly DP Rose 1999 The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines Int J Oncol 15 267 270 1:CAS:528:DyaK1MXltVWhtbo%3D 10402236
11. P Krishnamurthy DD Ross T Nakanishi K Bailey-Dell S Zhou KE Mercer B Sarkadi BP Sorrentino JD Schuetz 2004 The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme J Biol Chem 279 24218 24225 1:CAS:528:DC%2BD2cXksV2isb0%3D 10.1074/jbc.M313599200 15044468 (Pubitemid 38725283)
12. Y Li M Bhuiyan RM Mohammad FH Sarkar 1998 Induction of apoptosis in breast cancer cells by TPA Oncogene 17 2915 2920 1:CAS:528:DyaK1MXisVCjsg%3D%3D 10.1038/sj.onc.1202218 9879997
13. XH Liu DP Rose 1996 Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines Cancer Res 56 5125 5127 1:CAS:528:DyaK28XntFOnu78%3D 8912844
14. NB Liu T Peng C Pan YY Yao B Shen J Leng 2005 Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis World J Gastroenterol 11 6281 6287 1:CAS:528: DC%2BD28XntVeqtQ%3D%3D 16419156
15. Q Mao JD Unadkat 2005 Role of the breast cancer resistance protein (ABCG2) in drug transport Aaps J 7 E118 E133 1:CAS:528:DC%2BD2MXltlOqtrs%3D 10.1208/aapsj070112 16146333 (Pubitemid 41554295)
16. H Minderman A Suvannasankha KL O'Loughlin GL Scheffer RJ Scheper RW Robey MR Baer 2002 Flow cytometric analysis of breast cancer resistance protein expression and function Cytometry 48 59 65 1:CAS:528:DC%2BD38Xlt1Cgtro%3D 10.1002/cyto.10111 12116365 (Pubitemid 34591916)
17. K Miyake L Mickley T Litman Z Zhan R Robey B Cristensen M Brangi L Greenberger M Dean T Fojo SE Bates 1999 Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes Cancer Res 59 8 13 1:CAS:528:DyaK1MXmsFKqsQ%3D%3D 9892175
18. U Puhlmann C Ziemann G Ruedell H Vorwerk D Schaefer C Langebrake P Schuermann U Creutzig D Reinhardt 2005 Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resistance 1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells J Pharmacol Exp Ther 312 346 354 1:CAS:528:DC%2BD2MXhtVWmuro%3D 10.1124/jpet.104.071571 15501994 (Pubitemid 40096488)
19. C Ramachandran H Kunikane W You A Krishan 1998 Phorbol ester-induced P-glycoprotein phosphorylation and functionality in the HTB-123 human breast cancer cell line Biochem Pharmacol 56 709 718 1:CAS:528:DyaK1cXmtlCis7g%3D 10.1016/S0006-2952(98)00215-9 9751075 (Pubitemid 28454581)
20. MR Raspollini G Amunni A Villanucci V Boddi GL Taddei 2005 Increased cyclooxygenase-2 (COX-2) and P-glycoprotein-170 (MDR1) expression is associated with chemotherapy resistance and poor prognosis. Analysis in ovarian carcinoma patients with low and high survival Int J Gynecol Cancer 15 255 260 1:STN:280:DC%2BD2M7ptVyitA%3D%3D 10.1111/j.1525-1438.2005.15212.x 15823108 (Pubitemid 40396961)
21. D Ratnasinghe PJ Daschner MR Anver BH Kasprzak PR Taylor GC Yeh JA Tangrea 2001 Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible? Anticancer Res 21 2141 2147 1:CAS:528:DC%2BD3MXmt1ans7g%3D 11501838
22. DD Ross JE Karp TT Chen LA Doyle 2000 Expression of breast cancer resistance protein in blast cells from patients with acute leukemia Blood 96 365 368 1:CAS:528:DC%2BD3cXksVKjtLk%3D 10891476
23. Y Saikawa T Sugiura F Toriumi T Kubota K Suganuma S Isshiki Y Otani K Kumai M Kitajima 2004 Cyclooxygenase-2 gene induction causes CDDP resistance in colon cancer cell line, HCT-15 Anticancer Res 24 2723 2728 1:CAS:528: DC%2BD2cXhtVSjsLrM 15517878
24. SC Shen CH Ko KC Hsu YC Chen 2004 3-OH flavone inhibition of epidermal growth factor-induced proliferation through blocking prostaglandin E2 production Int J Cancer 108 502 510 1:CAS:528:DC%2BD2cXjvFSisg%3D%3D 10.1002/ijc.11581 14696113 (Pubitemid 38036649)
25. A Sorokin 2004 Cyclooxygenase-2: potential role in regulation of drug efflux and multidrug resistance phenotype Curr Pharm Des 10 647 657 1:CAS:528:DC%2BD2cXhvFOku7w%3D 10.2174/1381612043453117 14965327 (Pubitemid 38292391)
26. Y Su SH Lee PJ Sinko 2006 Inhibition of efflux transporter ABCG2/BCRP does not restore mitoxantrone sensitivity in irinotecan-selected human leukemia CPT-K5 cells: evidence for multifactorial multidrug resistance Eur J Pharm Sci 29 102 110 1:CAS:528:DC%2BD28XpsVWlsbY%3D 10.1016/j.ejps.2006.06.001 16844360 (Pubitemid 44332882)
27. K Subbaramaiah AJ Dannenberg 2003 Cyclooxygenase 2: a molecular target for cancer prevention and treatment Trends Pharmacol Sci 24 96 102 1:CAS:528:DC%2BD3sXmt1aktA%3D%3D 10.1016/S0165-6147(02)00043-3 12559775 (Pubitemid 36135884)
28. E Teodori S Dei S Scapecchi F Gualtieri 2002 The medicinal chemistry of multidrug resistance (MDR) reversing drugs Farmaco 57 385 415 1:CAS:528:DC%2BD38Xjt1Clt7w%3D 10.1016/S0014-827X(02)01229-6 12058813 (Pubitemid 34451020)
29. J van Wijngaarden E van Beek G van Rossum C van der Bent K Hoekman G van der Pluijm MA van der Pol HJ Broxterman VW van Hinsbergh CW Lowik 2007 Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation Eur J Cancer 43 433 442 10.1016/j.ejca.2006.09.010 17097285 (Pubitemid 46123984)
30. V Vital-Reyes C Rodriguez-Burford DC Chhieng DK Oelschlager A Reyes-Fuentes M Barnes WE Grizzle 2006 Celecoxib inhibits cellular growth, decreases Ki-67 expression and modifies apoptosis in ovarian cancer cell lines Arch Med Res 37 689 695 1:CAS:528:DC%2BD28Xms1Gmu7c%3D 10.1016/j.arcmed.2005.11. 014 16824926 (Pubitemid 43975166)
31. S Xu WQ Zhou ZY Zhang JP Ge JP Gao 2008 Effects of a selective cyclooxygenase 2 inhibitor celecoxib on the proliferation and apoptosis of human prostate cancer cell line PC-3 Zhonghua Nan Ke Xue 14 489 493 1:CAS:528:DC%2BD1MXntFOltLw%3D 18649743
32. MC Zatelli A Luchin F Tagliati S Leoni D Piccin M Bondanelli R Rossi EC degli Uberti 2007 Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression Endocr Relat Cancer 14 1029 1038 1:CAS:528:DC%2BD1cXivFagur4%3D 10.1677/ERC-07-0114 18045954 (Pubitemid 351252434)